|
When DADA2 was first discovered in 2014, very little was known about the role ADA2 played in the body. Since then, with the encouragement of the DADA2 Foundation, researchers have been attacking the issue from many research angles. The DADA2 Foundation reached out to Dr. Pui Lee of Harvard/Boston Children's Hospital to learn more about his research on the fundamental biology of ADA2 and why it is important for developing better treatments for DADA2.
Q: Dr. Lee, what are you hoping to understand through your current DADA2 research?
A: My team is trying to understand the chain of events that happens when the ADA2 enzyme is missing or not functioning properly. ADA2 normally helps regulate how certain immune cells behave β especially monocytes and macrophages. When ADA2 is low, these cells can shift into a more inflammatory state. We want to identify exactly how that shift occurs and why it leads to the symptoms families see in DADA2.
Q: Why is inflammation such an important part of this disease?
A: In DADA2, inflammation isnβt random β it comes from specific immune pathways becoming overactive. We are especially interested in how the loss of ADA2 leads to excess production of inflammatory cytokines, including TNF, and how this affects the lining of blood vessels. Understanding these pathways will help us explain why some people develop vasculitis or strokes, while others may experience immune deficiency or bone marrow problems.
Q: How could this research help people living with DADA2 right now?
A: Learning the underlying biology helps us refine treatment. For example, anti-TNF medications work for many families, but not all. By understanding the deeper... (more)
|